A Phase 1/2 interventional study of Placebo and Chloroquine in Dengue, sponsored by University of Sao Paulo. Status unknown at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2009-02-24.
Sponsored by University of Sao Paulo · Phase 1/2, Interventional, and Treatment
The objective of this study was to evaluate the effect of chloroquine in the treatment of patients with dengue.
279 studies on the registry are indexed under Dengue; 45 are open to participants now.
This study's planned enrollment of 132 is close to the median of 123 across 195 interventional studies indexed under Dengue.
Browse Dengue studies →University of Sao Paulo is the lead sponsor of 1,003 studies on the registry; 88 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients were included in the study if they presented with fever and at least two other symptoms, such as:
Exclusion Criteria:
Drug: Placebo
Drug: Chloroquine
Placebo bid for three days
Chloroquine bid for three days
Duration of the disease
Time frame: one week
Intensity and days of fever and symptoms
Time frame: one week
This study is status unknown, as verified in Feb 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Sao Paulo